McKenzie I F, Morgan G M, Sandrin M S, Michaelides M M, Melvold R W, Kohn H I
J Exp Med. 1979 Dec 1;150(6):1323-38. doi: 10.1084/jem.150.6.1323.
The B6.C-H-2bm12 mutant is described and evidence is presented for the mutational site occurring in the IA subregion. The mutant is of the gain and loss type as bm12 in equilibrium or formed from C57BL/6 grafts are rejected in 14-16 d. Mapping studies by the gene-complementation method using H-2 recombinant strains place the mutation in the K or IA regions of the H-2 complex and furthermore, the use of this test and the use of other H-2 mutants indicate that H-2Kb is not the site of the mutation, making the IA region the most likely site. Serological analysis with a battery of H-2b, Iab, and other Ia sera, both by cytotoxicity, rosetting, and also by absorption analysis, indicated no alteration in H-2 specificities, particularly in H-2.K33. By contrast, all of the Iab specificities coded for by the IA subregion (Ia.3, 8, 9, 15, and possibly 20) are extensively altered and are either absent or greatly reduced in amount indicating an extensive alteration in the Ia-bearing molecule. The bm12 mutant strongly stimulates the parental C57BL/6 strain in an mixed lymphocyte reaction (MLR), and the reciprocal also occurs, the degree of stimulation being similar to that obtained with K + IA differences originating in another H-2 haplotype and points to the mutation effecting the Lad-1 locus. The presence of an extensive histocompatibility change, a marked alteration in the serologically detected Ia specificities, and a strong MLR, all produced by the one mutation, provides strong evidence for the identity of the Ia-1, Lad-1, and H-2(IA) loci in the IA subregion. The bm12 mutant should be of value in determining the relationship of Ia specificities, Ir genes, and other phenomena effected by the I region.
描述了B6.C-H-2bm12突变体,并提供了突变位点位于IA亚区的证据。该突变体为得失型,因为处于平衡状态的bm12或由C57BL/6移植物形成的bm12在14 - 16天内被排斥。使用H-2重组菌株通过基因互补法进行的定位研究将突变定位在H-2复合体的K或IA区域,此外,使用该测试以及其他H-2突变体表明H-2Kb不是突变位点,使得IA区域成为最可能的位点。用一系列H-2b、Iab和其他Ia血清进行血清学分析,无论是通过细胞毒性、玫瑰花结试验还是吸收分析,均表明H-2特异性没有改变,特别是在H-2.K33方面。相比之下,IA亚区编码的所有Iab特异性(Ia.3、8、9、15以及可能的20)都发生了广泛改变,要么缺失,要么数量大幅减少,表明携带Ia的分子发生了广泛改变。bm12突变体在混合淋巴细胞反应(MLR)中强烈刺激亲代C57BL/6菌株,反之亦然,刺激程度与源自另一种H-2单倍型的K + IA差异所获得的刺激程度相似,这表明突变影响了Lad-1位点。由一个突变产生的广泛组织相容性变化、血清学检测到的Ia特异性的显著改变以及强烈的MLR,为IA亚区中Ia-1、Lad-1和H-2(IA)位点的同一性提供了有力证据。bm12突变体在确定Ia特异性、Ir基因以及I区域影响的其他现象之间的关系方面应该具有价值。